
Causaly is the leading AI platform for life sciences, combining advanced AI, a high-precision knowledge graph, and seamless adoption to enhance R&D productivity and mitigate risks. Their platform empowers R&D teams to find, interpret, and share biomedical information efficiently. Key products include Generative AI Copilot for asking complex biomedical questions, a Knowledge Graph for precise data analysis, an Enterprise Data Fabric for integrating internal and external data, and Scientific RAG for information retrieval. Causaly aims to accelerate drug discovery and development by providing scientists with a "single source of truth" and robust AI tools. The company was co-founded in 2018 by computer scientists Yiannis Kiachopoulos and Artur Saudabayev, with headquarters in London and offices in New York and Greece.

Causaly is the leading AI platform for life sciences, combining advanced AI, a high-precision knowledge graph, and seamless adoption to enhance R&D productivity and mitigate risks. Their platform empowers R&D teams to find, interpret, and share biomedical information efficiently. Key products include Generative AI Copilot for asking complex biomedical questions, a Knowledge Graph for precise data analysis, an Enterprise Data Fabric for integrating internal and external data, and Scientific RAG for information retrieval. Causaly aims to accelerate drug discovery and development by providing scientists with a "single source of truth" and robust AI tools. The company was co-founded in 2018 by computer scientists Yiannis Kiachopoulos and Artur Saudabayev, with headquarters in London and offices in New York and Greece.
What they do: Enterprise AI platform and high-precision biomedical knowledge graph to accelerate drug discovery and R&D
Founded: 2018
Headquarters / offices: London; offices in New York and Greece
Recent funding: Series B $60M (Jul 13, 2023); $93M total raised
Founders / leadership: Yiannis Kiachopoulos (CEO), Artur Saudabayev (CTO)
| Company |
|---|
Biomedical research and drug discovery R&D productivity and risk mitigation
2018
Software Development
60000000
Raised $60M; brought total funding to $93M
17000000
4800000
“Includes strategic and growth investors such as ICONIQ Growth, Index Ventures, Marathon Venture Capital, EBRD Venture Capital, Pentech Ventures and individual strategic backers”
Founded in 2018, Causaly’s AI platform for enterprise-scale scientific research redefines the limits of human productivity. We give humans a powerful new way to find, visualize and interpret biomedical knowledge and automate critical research workflows, accelerating solutions for some of the greatest health challenges we face.
We work with some of the world's largest biopharma companies and institutions on use cases spanning Drug Discovery, Safety and Competitive Intelligence. You can read more about how we accelerate knowledge acquisition and improve decision making in our blog posts here: Blog - Causaly
We are backed by top VCs including ICONIQ, Index Ventures, Pentech and Marathon.
Role Summary Causaly is already an established B2B enterprise product, trusted by leading pharmaceutical companies to drive scientific decisions with speed and rigor. Now we’re taking the next step: bringing that same step-change in productivity to scientists everywhere .
Our ambition is big and explicit: make Causaly the default scientific productivity tool for the world . That means expanding beyond enterprise pharma into academia , small and mid-sized biotech , life science professionals , hospital and translational researchers , and other research-driven environments where evidence, traceability, and speed matter. We will set aggressive growth targets and build a second growth engine that can scale independently and sustainably.
This role sits at the center of that ambition. You’ll operate with high autonomy —think like a GM for the motion —and you’ll build the engine from scratch: the growth model, the loops, the operating cadence, and the metrics. It’s a builder role for someone with a founder mentality who wants to own outcomes end-to-end.
You’ll do it on the cutting edge: our product foundation is Agentic Research , enabling AI-native scientific workflows that can be adopted by the masses with minimal training. And you’ll be expected to move fast by default—leveraging modern AI-native growth tooling (AI SDRs, AI lifecycle + nudges, automated experimentation/insight loops) and tight iteration with engineering to ship new hooks quickly and compound learnings at high velocity.
Responsibilities
Key Qualifications
Nice-to-haves
Benefits 💰 Competitive compensation package 🤓 Personal development budget 🧘 Individual wellbeing budget 🥳 Your birthday off! ♾️ Unlimited time off 🧑🍼 12 weeks paid parental leave (after 6 months) 🚀 Potential to have real impact and accelerated career growth as a member of an international team that’s building a transformative AI product.
We are on a mission to accelerate scientific breakthroughs for ALL humankind, and we are proud to be an equal opportunity employer. We welcome applications from all backgrounds and fairly consider qualified candidates without regard to race, ethnic or national origin, gender, gender identity or expression, sexual orientation, disability, neurodiversity, genetics, age, religion or belief, marital/civil partnership status, domestic / family status, veteran status or any other difference.
Compensation Range: $180K - $220K